Relmada Therapeutics Inc RLMD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/18/21 EDT
30.90UNCH (UNCH)
Volume
4,950
Close
30.90quote price arrow down-0.96 (-3.01%)
Volume
97,931
52 week range
28.40 - 54.00

...

Loading . . .
  • Open31.61
  • Day High31.74
  • Day Low30.48
  • Prev Close31.86
  • 52 Week High54.00
  • 52 Week High Date06/25/20
  • 52 Week Low28.40
  • 52 Week Low Date10/28/20

Key Stats

  • Market Cap517.57M
  • Shares Out16.75M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta0.33
  • YTD % Change-3.65

KEY STATS

  • Open31.61
  • Day High31.74
  • Day Low30.48
  • Prev Close31.86
  • 52 Week High54.00
  • 52 Week High Date06/25/20
  • 52 Week Low28.40
  • 52 Week Low Date10/28/20
  • Market Cap517.57M
  • Shares Out16.75M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta0.33
  • YTD % Change-3.65

RATIOS/PROFITABILITY

  • EPS (TTM)-4.40
  • P/E (TTM)-7.03
  • Fwd P/E (NTM)-5.13
  • EBITDA (MRQ)-73.266M
  • ROE (MRQ)-69.50%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/10/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Relmada Therapeutics Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for central nervous system (CNS) disorders. Its product candidate includes dextromethadone (d-methadone), REL-1017, REL-1015 (LevoCap ER), REL-1028 (BuTab) and REL-1021 (MepiGel). d-methadone (dextromethadone, REL-1017) is an N-methyl-D-aspartate (NMDA) receptor antagonist. d-methadone is a new chemical entity (NCE) that is being developed for the treatment of...
Charles Casamento
Non-Executive Chairman
Sergio Traversa Pharm.D.
Chief Executive Officer
Maged Shenouda
Chief Financial Officer
Charles Ence
Chief Accounting Officer
Address
880 3rd Ave Fl 12
New York, NY
10022-4730
United States

Top Peers

SYMBOLLASTCHG%CHG
SIGA
SIGA Technologies Inc
6.37-0.13-2.00%
TNXP
Tonix Pharmaceuticals Holding Corp
1.22UNCHUNCH
AVDL
Avadel Pharmaceuticals PLC
7.85UNCHUNCH
SPPI
Spectrum Pharmaceuticals Inc
4.27-0.07-1.61%
GTBP
GT Biopharma Inc
17.98-0.01-0.06%